Literature DB >> 12099372

Cytomegalovirus (CMV) resistance to antivirals.

W L Drew1, C V Paya, V Emery.   

Abstract

This article reviews the biology of cytomegalovirus (CMV), the approved antiviral therapies, and mechanisms of resistance to these drugs. The rates of resistance development in clinical trials are presented, as are the assays for testing susceptibility by phenotypic and genotypic methods. Factors that favor the development of clinical and in vitro antiviral resistance are discussed. Finally, approaches to altering antiviral therapy as resistance develops are outlined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12099372

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  13 in total

1.  Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.

Authors:  Egor P Tchesnokov; Christian Gilbert; Guy Boivin; Matthias Götte
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.

Authors:  T Ueno; Y Eizuru; H Katano; T Kurata; T Sata; S Irie; K Ogawa-Goto
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

3.  Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89.

Authors:  Brian G Gentry; Quang Phan; Ellie D Hall; Julie M Breitenbach; Katherine Z Borysko; Jeremy P Kamil; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Gastrointestinal Infections Caused by Cytomegalovirus.

Authors:  David A. Bobak
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

6.  Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus.

Authors:  Mark R Underwood; Robert G Ferris; Dean W Selleseth; Michelle G Davis; John C Drach; Leroy B Townsend; Karen K Biron; F Leslie Boyd
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule.

Authors:  Thomas R Jones; Shi-Wu Lee; Stephen V Johann; Vladimir Razinkov; Robert J Visalli; Boris Feld; Jonathan D Bloom; John O'Connell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 8.  Viral infection after renal transplantation: surveillance and management.

Authors:  Blair C Weikert; Emily A Blumberg
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

Review 9.  Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation.

Authors:  Lionel Couzi; Vincent Pitard; Jean-François Moreau; Pierre Merville; Julie Déchanet-Merville
Journal:  Front Immunol       Date:  2015-01-21       Impact factor: 7.561

10.  Pentostatin antagonizes the antiviral activity of MBX-2168 by inhibiting the biosynthesis of the active compound.

Authors:  Natalie R Hagen; Marie L Nguyen; John D Williams; Terry L Bowlin; Brian G Gentry
Journal:  Antiviral Res       Date:  2021-01-18       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.